Send the following on WhatsApp
Continue to ChatKaryopharm 和 Menarini Group 就 NEXPOVIO® (selinexor) 治療難治多發性骨髓瘤患者獲得人用藥物產品委員會的正面意見 https://geneonline.news/karyopharm-%e5%92%8c-menarini-group-%e5%b0%b1-nexpovio-selinexor-%e6%b2%bb%e7%99%82%e9%9b%a3%e6%b2%bb%e5%a4%9a%e7%99%bc%e6%80%a7%e9%aa%a8%e9%ab%93%e7%98%a4%e6%82%a3%e8%80%85%e7%8d%b2%e5%be%97/